Aspen Pharmacare Holdings Ltd
F:LDZU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aspen Pharmacare Holdings Ltd
F:LDZU
|
ZA |
|
V
|
Vertex Pharmaceuticals Inc
BMV:VRTX
|
US |
|
H
|
HSBC Holdings PLC
XMUN:HBC1
|
UK |
|
Lumentum Holdings Inc
NASDAQ:LITE
|
US |
|
BROOKFIELD ASSET MANAGEMENT LTD
F:RW5
|
US |
|
D
|
DoorDash Inc
F:DD2
|
US |
|
I
|
Industrivarden AB
SWB:IDVA
|
SE |
|
B
|
Brown-Forman Corp
SWB:BF5B
|
US |
|
A
|
Amphenol Corp
DUS:XPH
|
US |
|
S
|
SAP SE
SWB:SAP
|
DE |
|
Deutsche Bank AG
MIL:DBK
|
DE |
Wall St Price Targets
LDZU Price Targets Summary
Aspen Pharmacare Holdings Ltd
According to Wall Street analysts, the average 1-year price target for LDZU is 8.41 EUR with a low forecast of 7.57 EUR and a high forecast of 9.84 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LDZU's stock price target?
Price Target
8.41
EUR
According to Wall Street analysts, the average 1-year price target for LDZU is 8.41 EUR with a low forecast of 7.57 EUR and a high forecast of 9.84 EUR.
What is the Revenue forecast for Aspen Pharmacare Holdings Ltd?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 1%.
What is the Gross Profit forecast for Aspen Pharmacare Holdings Ltd?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is 3%.
What is the Operating Income forecast for Aspen Pharmacare Holdings Ltd?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 3 years is 4%.
